Radiology of soft tissue tumors including melanoma

Cancer Treatment and Research

Volumn 143, Issue , 2008, Pages 423-452

  Shelly, M J ^a   Macmahon, P J ^a   Eustace, S ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b CAPPAGH NATIONAL ORTHOPAEDIC HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; LIPOMA; LIPOSARCOMA; MELANOMA; METHODOLOGY; MUSCLE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REVIEW; SARCOMA; SOFT TISSUE TUMOR; WHOLE BODY IMAGING;

BIOPSY; DIAGNOSTIC IMAGING; HUMANS; LIPOMA; LIPOSARCOMA; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; MELANOMA; MUSCLE NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; WHOLE BODY IMAGING;

MLCS; MLOWN;

EID: 48249099296     PISSN: 09273042     EISSN: 25098497     Source Type: Book Series    
DOI: 10.1007/978-0-387-75587-8_16     Document Type: Article

References (113)

1. Rosenberg A. Bones, Joints, and Soft Tissue Tumors. In: Cotran RS, Kumar V, Collins T, editors. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders; 1999. 1259-1267.
2. Brady MS, Gaynor JJ, Brennan MF. Radiation-associated sarcoma of bone and soft tissue. Arch Surg 1992; 127(12):1379-1385.
3. Brennan MF. The surgeon as a leader in cancer care: Lessons learned from the study of soft tissue sarcoma. J Am Coll Surg 1996; 182(6):520-529.
4. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centres Sarcoma Group grading systems in a population of 420 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15(1):350-362.
5. Heslin MJ, Smith JK. Imaging of soft tissue sarcomas. Surg Oncol Clin N Am 1999; 8(1):91-107.
6. Sanders TG, Parsons TW, III. Radiographic imaging of musculoskeletal neoplasia. Cancer Control 2001; 8(3):221-231.
7. Ilaslan H, Sundaram M. Advances in musculoskeletal tumor imaging. Orthop Clin North Am 2006; 37(3):375-91, vii.
8. CKERMAN LV. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): Clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am 1958; 40-A(2):279-298.
9. Levine E, Lee KR, Neff JR, Maklad NF, Robinson RG, Preston DF. Comparison of computed tomography and other imaging modalities in the evaluation of musculoskeletal tumors. Radiology 1979; 131(2):431-437.
10. Martel W, Abell MR. Radiologic evaluation of soft tissue tumors. A retrospective study. Cancer 1973; 32(2):352-366.
11. Kransdorf MJ, Jelinek JS, Moser RP, Jr. Imaging of soft tissue tumors. Radiol Clin North Am 1993; 31(2):359-372.
12. Chew FS, Hudson TM, Enneking WF. Radionuclide imaging of soft tissue neoplasms. Semin Nucl Med 1981; 11(4):266-276.
13. Fornage BD. Soft tissue masses. Clin Diagn Ultrasound 1995; 30:21-42.
14. Taylor GA, Perlman EJ, Scherer LR, Gearhart JP, Leventhal BG, Wiley J. Vascularity of tumors in children: Evaluation with color Doppler imaging. AJR Am J Roentgenol 1991; 157(6):1267-1271.
15. Eskey CJ, Robson CD, Weber AL. Imaging of benign and malignant soft tissue tumors of the neck. Radiol Clin North Am 2000; 38(5):1091-104, xi.
16. Richardson ML, Gillespy T. Magnetic Resonance Imaging. In: Kricun ME, editor. Imaging of bone tumors. Philadelphia: WB Saunders; 1993. 358-446.
17. Cheng EY, Thompson RC, Jr. New developments in the staging and imaging of soft tissue sarcomas. Instr Course Lect 2000; 49:443-451.
18. Reddick WE, Wang S, Xiong X, Glass JO, Wu S, Kaste SC et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric oste-osarcoma. Cancer 2001; 91(12):2230-2237.
19. Kole AC, Nieweg OE, van Ginkel RJ, Pruim J, Hoekstra HJ, Paans AM et al. Detection of local recurrence of soft tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose. Ann Surg Oncol 1997; 4(1):57-63.
20. Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB, Conrad EU, III et al. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 2005; 23(34):8828-8834.
21. Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU, III et al. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoad-juvant chemotherapy. Cancer 2005; 103(2):339-348.
22. Jones DN, McCowage GB, Sostman HD, Brizel DM, Layfield L, Charles HC et al. Monitoring of neoadjuvant therapy response of soft tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. J Nucl Med 1996; 37(9):1438-1444.
23. Hawkins DS, Rajendran JG, Conrad EU, III, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002; 94(12):3277-3284.
24. Folpe AL, Lyles RH, Sprouse JT, Conrad EU, III, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000; 6(4):1279-1287.
25. McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005; 184(4):1293-1304.
26. Wegner EA, Barrington SF, Kingston JE, Robinson RO, Ferner RE, Taj M et al. The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging 2005; 32(1):23-30.
27. Lucas JD, O'Doherty MJ, Cronin BF, Marsden PK, Lodge MA, McKee PH et al. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg 1999; 86(4):550-556.
28. Lucas JD, O'Doherty MJ, Wong JC, Bingham JB, McKee PH, Fletcher CD et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft tissue sarcomas. J Bone Joint Surg Br 1998; 80(3):441-447.
29. Siegel BA, Dehdashti F. Oncologic PET/CT: Current status and controversies. Eur Radiol 2005; 15 Suppl 4:D127-D132.
30. Conrad EU, III, Morgan HD, Vernon C, Schuetze SM, Eary JF. Fluorodeoxyglucose positron emission tomography scanning: Basic principles and imaging of adult soft tissue sarcomas. J Bone Joint Surg Am 2004; 86-A Suppl 2:98-104.
31. Aoki J, Endo K, Watanabe H, Shinozaki T, Yanagawa T, Ahmed AR et al. FDG-PET for evaluating musculoskeletal tumors: A review. J Orthop Sci 2003; 8(3):435-441.
32. Kole AC, Nieweg OE, Hoekstra HJ, van H, Jr., Koops HS, Vaalburg W. Fluorine-18-fluorode-oxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med 1998; 39(5):810-815.
33. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Tokunaga M, Koyama Y et al. FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol 2003; 32(3):133-138.
34. Ben Arush MW, Bar SR, Postovsky S, Militianu D, Haimi M, Zaidman I et al. Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. J Pediatr Hematol Oncol 2006; 28(7):440-445.
35. Schuetze SM. Utility of positron emission tomography in sarcomas. Curr Opin Oncol 2006; 18(4):369-373.
36. Schuetze SM. Imaging and response in soft tissue sarcomas. Hematol Oncol Clin North Am 2005; 19(3):471-87, vi.
37. Yao L, Nelson SD, Seeger LL, Eckardt JJ, Eilber FR. Primary musculoskeletal neoplasms: Effectiveness of core-needle biopsy. Radiology 1999; 212(3):682-686.
38. Dupuy DE, Rosenberg AE, Punyaratabandhu T, Tan MH, Mankin HJ. Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol 1998; 171(3):759-762.
39. Silverman SG, Tuncali K, Adams DF, Nawfel RD, Zou KH, Judy PF. CT fluoroscopy-guided abdominal interventions: Techniques, results, and radiation exposure. Radiology 1999; 212(3):673-681.
40. Fletcher JA. Soft Tissue Tumors. St. Louis: Mosby; 1995.
41. Ahuja AT, King AD, Kew J, King W, Metreweli C. Head and neck lipomas: Sonographic appearance. AJNR Am J Neuroradiol 1998; 19(3):505-508.
42. Gritzmann N, Schratter M, Traxler M, Helmer M. Sonography and computed tomography in deep cervical lipomas and lipomatosis of the neck. J Ultrasound Med 1988; 7(8):451-456.
43. Fornage BD, Tassin GB. Sonographic appearances of superficial soft tissue lipomas. J Clin Ultrasound 1991; 19(4):215-220.
44. Hosono M, Kobayashi H, Fujimoto R, Kotoura Y, Tsuboyama T, Matsusue Y et al. Septumlike structures in lipoma and liposarcoma: MR imaging and pathologic correlation. Skeletal Radiol 1997; 26(3):150-154.
45. Gaskin CM, Helms CA. Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas): Results of MRI evaluations of 126 consecutive fatty masses. AJR Am J Roentgenol 2004; 182(3):733-739.
46. Stewart MG, Schwartz MR, Alford BR. Atypical and malignant lipomatous lesions of the head and neck. Arch Otolaryngol Head Neck Surg 1994; 120(10):1151-1155.
47. Einarsdottir H, Soderlund V, Larsson O, Mandahl N, Bauer HC. 110 subfascial lipomatous tumors. MR and CT findings versus histopathological diagnosis and cytogenetic analysis. Acta Radiol 1999; 40(6):603-609.
48. Enzinger FM, Weiss SW. Soft Tissue Tumors. 3rd ed. St Louis: Mosby; 1995.
49. Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. Philadelphia: WB Saunders; 1997.
50. Eich GF, Hoeffel JC, Tschappeler H, Gassner I, Willi UV. Fibrous tumors in children: Imaging features of a heterogeneous group of disorders. Pediatr Radiol 1998; 28(7):500-509.
51. Quinn SF, Erickson SJ, Dee PM, Walling A, Hackbarth DA, Knudson GJ et al. MR imaging in fibromatosis: Results in 26 patients with pathologic correlation. AJR Am J Roentgenol 1991; 156(3):539-542.
52. Hartman TE, Berquist TH, Fetsch JF. MR imaging of extraabdominal desmoids: Differentiation from other neoplasms. AJR Am J Roentgenol 1992; 158(3):581-585.
53. Patel SC, Silbergleit R, Talati SJ. Sarcomas of the head and neck. Top Magn Reson Imaging 1999; 10(6):362-375.
54. O'Connell TE, Castillo M, Mukherji SK. Fibrosarcoma arising in the maxillary sinus: CT and MR features. J Comput Assist Tomogr 1996; 20(5):736-738.
55. White LM, Buckwalter KA. Technical considerations: CT and MR imaging in the postoperative orthopedic patient. Semin Musculoskelet Radiol 2002; 6(1):5-17.
56. Mahajan H, Kim EE, Wallace S, Abello R, Benjamin R, Evans HL. Magnetic resonance imaging of malignant fibrous histiocytoma. Magn Reson Imaging 1989; 7(3):283-288.
57. Munk PL, Sallomi DF, Janzen DL, Lee MJ, Connell DG, O'Connell JX et al. Malignant fibrous histiocytoma of soft tissue imaging with emphasis on MRI. J Comput Assist Tomogr 1998; 22(5):819-826.
58. Helmberger RC, Stringer SP, Mancuso AA. Rhabdomyoma of the pharyngeal musculature extending into the prestyloid parapharyngeal space. AJNR Am J Neuroradiol 1996; 17(6):1115-1118.
59. Freije JE, Gluckman JL, Biddinger PW, Wiot G. Muscle tumors in the parapharyngeal space. Head Neck 1992; 14(1):49-54.
60. Vermeersch H, van VP, Lemmerling M, Moerman M, De PC. Bilateral recurrent adult rhab-domyomas of the pharyngeal wall. Eur Arch Otorhinolaryngol 2000; 257(1):24-26.
61. Malogolowkin MH, Ortega JA. Rhabdomyosarcoma of childhood. Pediatr Ann 1988; 17(4):251, 254-251, 268.
62. Pappo AS, Shapiro DN, Crist WM. Rhabdomyosarcoma. Biology and treatment. Pediatr Clin North Am 1997; 44(4):953-972.
63. Yousem DM, Lexa FJ, Bilaniuk LT, Zimmerman RI. Rhabdomyosarcomas in the head and neck: MR imaging evaluation. Radiology 1990; 177(3):683-686.
64. Betts MT, Huo EJ, Miller FH. Gastrointestinal and genitourinary smooth-muscle tumors. AJR Am J Roentgenol 2003; 181(5):1349-1354.
65. Hines OJ, Nelson S, Quinones-Baldrich WJ, Eilber FR. Leiomyosarcoma of the inferior vena cava: Prognosis and comparison with leiomyosarcoma of other anatomic sites. Cancer 1999; 85(5):1077-1083.
66. McLeod AJ, Zornoza J, Shirkhoda A. Leiomyosarcoma: Computed tomographic findings. Radiology 1984; 152(1):133-136.
67. Ohnishi T, Yoshioka H, Ishida O. MR imaging of gastrointestinal leiomyosarcoma. Radiat Med 1991; 9(3):114-117.
68. Chen JJ, Changchien CS, Chiou SS, Tai DI, Lee CM, Kuo CH. Various sonographic patterns of smooth muscle tumors of the gastrointestinal tract: A comparison with computed tomography. J Ultrasound Med 1992; 11(10):527-531.
69. Schoen FJ, Cotran RS. Blood Vessels. In: Cotran RS, Kumar V, Collins T, editors. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders; 1999. 531-538.
70. Greenspan A, McGahan JP, Vogelsang P, Szabo RM. Imaging strategies in the evaluation of soft tissue hemangiomas of the extremities: Correlation of the findings of plain radiography, angiography, CT, MRI, and ultrasonography in 12 histologically proven cases. Skeletal Radiol 1992; 21(1):11-18.
71. Woodward AH, Ivins JC, Soule EH. Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 1972; 30(2):562-572.
72. Nakazono T, Kudo S, Matsuo Y, Matsubayashi R, Ehara S, Narisawa H et al. Angiosarcoma associated with chronic lymphedema (Stewart-Treves syndrome) of the leg: MR imaging. Skeletal Radiol 2000; 29(7):413-416.
73. Worawattanakul S, Semelka RC, Kelekis NL, Woosley JT. Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy. Magn Reson Imaging 1997; 15(5):613-617.
74. De Girolami U, Anthony DC, Frosch MP. The Central Nervous System. In: Cotran RS, Kumar V, Collins T, editors. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders; 1999. 1352-1354.
75. Hughes DG, Wilson DJ. Ultrasound appearances of peripheral nerve tumors. Br J Radiol 1986; 59(706):1041-1043.
76. Fornage BD. Peripheral nerves of the extremities: Imaging with US. Radiology 1988; 167(1):179-182.
77. Kuo CH, Changchien CS. Sonographic features of retroperitoneal neurilemoma. J Clin Ultrasound 1993; 21(5):309-312.
78. Cohen LM, Schwartz AM, Rockoff SD. Benign schwannomas: Pathologic basis for CT inhomogeneities. AJR Am J Roentgenol 1986; 147(1):141-143.
79. Hughes DG, Wilson DJ. Ultrasound appearances of peripheral nerve tumors. Br J Radiol 1986; 59(706):1041-1043.
80. Chui MC, Bird BL, Rogers J. Extracranial and extraspinal nerve sheath tumors: Computed tomographic evaluation. Neuroradiology 1988; 30(1):47-53.
81. Kumar AJ, Kuhajda FP, Martinez CR, Fishman EK, Jezic DV, Siegelman SS. Computed tomography of extracranial nerve sheath tumors with pathological correlation. J Comput Assist Tomogr 1983; 7(5):857-865.
82. Armstrong SJ, Watt I. Imaging of soft tissue tumors. Curr Opin Radiol 1992; 4(6):39-44.
83. Beggs I. Pictorial review: Imaging of peripheral nerve tumors. Clin Radiol 1997; 52(1):8-17.
84. Stull MA, Moser RP, Jr., Kransdorf MJ, Bogumill GP, Nelson MC. Magnetic resonance appearance of peripheral nerve sheath tumors. Skeletal Radiol 1991; 20(1):9-14.
85. Burk DL, Jr., Brunberg JA, Kanal E, Latchaw RE, Wolf GL. Spinal and paraspinal neurofi-bromatosis: Surface coil MR imaging at 1.5 T1. Radiology 1987; 162(3):797-801.
86. Gossios KJ, Guy RL. Case report: Imaging of widespread plexiform neurofibromatosis. Clin Radiol 1993; 47(3):211-213.
87. Suh JS, Abenoza P, Galloway HR, Everson LI, Griffiths HJ. Peripheral (extracranial) nerve tumors: Correlation of MR imaging and histologic findings. Radiology 1992; 183(2):341-346.
88. Ferner RE, Lucas JD, O'Doherty MJ, Hughes RA, Smith MA, Cronin BF et al. Evaluation of (18)fluorodeoxyglucose positron emission tomography ( (18)FDG PET) in the detection of malignant peripheral nerve sheath tumors arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 2000; 68(3):353-357.
89. Terry DG, Sauser DD, Gordon MD. Intraosseous malignant peripheral nerve sheath tumor in a patient with neurofibromatosis. Skeletal Radiol 1998; 27(6):346-349.
90. Fornage BD. Peripheral nerves of the extremities: Imaging with US. Radiology 1988; 167(1):179-182.
91. Levine E, Huntrakoon M, Wetzel LH. Malignant nerve-sheath neoplasms in neurofibromato-sis: Distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol 1987; 149(5):1059-1064.
92. Cardona S, Schwarzbach M, Hinz U, mitrakopoulou-Strauss A, Attigah N, Mechtersheimer section et al. Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumors. Eur J Surg Oncol 2003; 29(6):536-541.
93. McCarville MB, Spunt SL, Skapek SX, Pappo AS. Synovial sarcoma in pediatric patients. AJR Am J Roentgenol 2002; 179(3):797-801.
94. Murphey MD, Gibson MS, Jennings BT, Crespo-Rodriguez AM, Fanburg-Smith J, Gajewski DA. From the archives of the AFIP: Imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics 2006; 26(5):1543-1565.
95. Horowitz AL, Resnick D, Watson RC. The roentgen features of synovial sarcomas. Clin Radiol 1973; 24(4):481-484.
96. Rice S, Stewart CA. Synovial sarcoma seen on bone scan. Clin Nucl Med 1990; 15(6):445-446.
97. Tateishi U, Hasegawa T, Beppu Y, Satake M, Moriyama N. Synovial sarcoma of the soft tissues: Prognostic significance of imaging features. J Comput Assist Tomogr 2004; 28(1):140-148.
98. Morton MJ, Berquist TH, McLeod RA, Unni KK, Sim FH. MR imaging of synovial sarcoma. AJR Am J Roentgenol 1991; 156(2):337-340.
99. Jones BC, Sundaram M, Kransdorf MJ. Synovial sarcoma: MR imaging findings in 34 patients. AJR Am J Roentgenol 1993; 161(4):827-830.
100. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55(1):10-30.
101. Murphy GF, Mihm MC. The skin. In: Cotran RS, Kumar V, Collins T, editors. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders; 1999. 1177-1186.
102. Mihm MC, Jr., Clark WH, Jr., From L. The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med 1971; 284(19):1078-1082.
103. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172(5):902-908.
104. Clark WH, Jr., Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81(24):1893-1904.
105. Essner R, Belhocine T, Scott AM, Even-Sapir E. Novel imaging techniques in melanoma. Surg Oncol Clin N Am 2006; 15(2):253-283.
106. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230(4):453-463.
107. Escott EJ. A variety of appearances of malignant melanoma in the head: A review. Radiographics 2001; 21(3):625-639.
108. Cochran AJ, Balda BR, Starz H, Bachter D, Krag DN, Cruse CW et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89(2):236-241.
109. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17(3):976-983.
110. Schoder H, Larson SM, Yeung HW. PET/CT in oncology: Integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004; 45 Suppl 1:72S-81S.
111. Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K et al. A review of the literature for whole-body FDG PET in the management of patients with melanoma. Q J Nucl Med 2000; 44(2):153-167.
112. Schillaci O. Hybrid SPECT/CT: A new era for SPECT imaging? Eur J Nucl Med Mol Imaging 2005; 32(5):521-524.
113. Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F. Application of an [(18)F] fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001; 96(1):120-126.